CNTX Context Therapeutics Inc.
Nasdaq · SEC CIK 1842952 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 71 since 2021-10-25, latest 2026-06-26 16:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 25
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | 2025-06-06 | CNTX | Minai-Azary Jennifer Lynn | CFO | P - Purchase | $0.64 | +40.0K | 80.0K | +100% | +$25.6K | |
| I | 2025-06-10 | 2025-06-09 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.7 | +100.0K | 920.2K | +12% | +$70.0K |
| 2025-06-10 | 2025-06-06 | CNTX | Levit Alex C. | CLO, Corp. Sec | P - Purchase | $0.58 | +20.0K | 29.0K | +222% | +$11.6K | |
| 2023-02-21 | 2023-02-21 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.84 | +5,823 | 159.7K | +4% | +$4,891 | |
| 2023-02-13 | 2023-02-13 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.87 | +5,606 | 153.9K | +4% | +$4,877 | |
| 2023-02-06 | 2023-02-06 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.97 | +5,040 | 148.3K | +4% | +$4,889 | |
| 2023-01-30 | 2023-01-30 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.7 | +7,027 | 143.2K | +5% | +$4,919 | |
| 2023-01-23 | 2023-01-23 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.72 | +6,839 | 136.2K | +5% | +$4,924 | |
| 2023-01-18 | 2023-01-17 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.74 | +6,783 | 129.4K | +6% | +$5,019 | |
| 2022-12-19 | 2022-12-16 | CNTX | Minai-Azary Jennifer Lynn | CFO | P - Purchase | $0.74 | +25.0K | 40.0K | +167% | +$18.5K | |
| 2022-12-19 | 2022-12-16 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $0.74 | +20.0K | 122.6K | +19% | +$14.8K | |
| 2022-12-12 | 2022-12-09 | CNTX | Levit Alex C. | CLO, Corp. Sec | P - Purchase | $0.85 | +6,000 | 9,000 | +200% | +$5,100 | |
| 2022-08-22 | 2022-08-19 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $1.85 | +13.0K | 102.6K | +15% | +$24.1K | |
| 2022-08-17 | 2022-08-16 | CNTX | Sahmoud Tarek | Chief Medical Off | P - Purchase | $1.95 | +10.0K | 10.0K | New | +$19.5K | |
| 2022-08-17 | 2022-08-17 | CNTX | Minai-Azary Jennifer Lynn | CFO | P - Purchase | $1.80 | +15.0K | 15.0K | New | +$27.0K | |
| I | 2021-12-20 | 2021-12-16 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $3.22 | +13.0K | 820.2K | +2% | +$41.9K |
| DA | 2021-12-17 | 2021-10-22 | CNTX | Dick Evan G. | SVP of R, D | C - Cnv Deriv | — | +26.6K | 83.0K | +47% | — |
| DMAI | 2021-12-17 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | +797.2K | 210.7K | New | — |
| DAI | 2021-12-17 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $5.00 | +10.0K | 807.2K | +1% | +$50.0K |
| DAI | 2021-12-17 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | O - OTM Ex | $7.14 | +52.7K | 0 | New | +$376.1K |
| 2021-10-25 | 2021-10-22 | CNTX | Levit Alex C. | CLO, Corp. Sec | P - Purchase | $5.00 | +3,000 | 3,000 | New | +$15.0K | |
| DMI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | +797.2K | 849.9K | +1,513% | — |
| D | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $5.00 | +10.0K | 99.6K | +11% | +$50.0K |
| DI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | O - OTM Ex | $7.14 | +52.7K | 52.7K | New | +$376.1K |
| D | 2021-10-25 | 2021-10-22 | CNTX | Dick Evan G. | SVP of R, D | C - Cnv Deriv | — | +26.6K | 87.1K | +44% | — |
Purchase Sale Sale after option exercise All abbreviations